Deal Insignt: Antibe licensed otenaproxesul to Nuance Pharma
Antibe Therapeutics Inc. licensed otenaproxesul to Nuance Pharma for commercialization in the Greater China region. Nuance is a biopharmaceutical company focused on... Read More
ViiV Healthcare’s Rukobia received EMA marketing authorisation
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc and Shionogi Limited as shareholders, announced... Read More
Sanofi received additional indication approval for Plavix
European Commission (EC) has approved an additional indication for Plavix (clopidogrel) to include its use in combination with aspirin in adult patients... Read More
What is the meaning of pharmaceutical profiling?
Pharmaceutical profiling assays helps to measure the properties of large numbers of drug candidates at the earliest stages of discovery. It is... Read More
Covishield received emergency use authorization in India
Covidshield vaccine, developed by AstraZeneca and Oxford University has received for emergency use authorization in India. Drugs Controller General of India (DCGI)... Read More
Myovant and Pfizer’s $4.2 Billion Deal for Orgovyx
Myovant Sciences is partnering with Pfizer to develop and commercialize Orgovyx for prostate cancer and women’s health. Orgovyx is the brand of... Read More
UK approves Pfizer-BioNTech’s COVID-19 vaccine. Rollout in week time
The UK today became the first country to approve the Covid-19 vaccine developed by Pfizer Inc and its German partner BioNTech SE.... Read More
Case Study: Clinical basis of MHLW approval of Astellas’s Evrenzo to treat anemia of CKD in adult patients not on dialysis
Posted on28 Nov 2020
Comments0
Astellas Pharma Inc. and FibroGen, Inc. announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved Evrenzo (roxadustat) for the treatment... Read More
Covid 19 Vaccine development and commercialization status | More than 50 vaccine candidate under development
Posted on28 Nov 2020
Comments0
More than 50 covid-19 vaccine candidate is currently under development. Here you can have the close look into the development status of... Read More
AbbVie, Eisai received new indication approval for Humira to treat pyoderma gangrenosum
AbbVie GK and Eisai Co, Ltd announced an approval of additional indication of Humira, a fully human anti-TNFa monoclonal antibody, for the... Read More